Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Proud

Showing results (191-200 of 465) with videos related to

Pageof 47
Sort By:
FEBS Letters|August 15, 1977
Amino acid sequences at the two sites on glycogen synthetase phosphorylated by cyclic AMP-dependent protein kinase and their dephosphorylation by protein phosphatase-IIIC G Proud, D B Rylatt, S J Yeaman, et al.
Advances in Biological Regulation|May 24, 2014
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple rolesJustin W Kenney, Claire E Moore, Xuemin Wang, et al.
The British Journal of Surgery|February 1, 1986
Aspirate cellularity as a rapid indicator of renal allograft rejectionR G Wilson, B K Shenton, R M Taylor, et al.
Scientific Reports|February 8, 2019
The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1Shervi Lie, Tingting Wang, Briony Forbes, et al.
Transfusion Medicine (Oxford, England)|December 1, 1991
Transfusion-induced immunosuppression and red cell clearanceP K Donnelly, G Proud, B K Shenton, et al.
The British Journal of Radiology|September 1, 1986
Computed tomography and sonography of cystic adventitial diseaseT P Fitzjohn, F E White, H W Loose, et al.
Transplantation|September 1, 1985
Control values of lymphocyte subsets in healthy volunteersT W Lennard, B K Shenton, G Proud, et al.
The Biochemical Journal|March 11, 2005
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Mark Rolfe, Laura E McLeod, Phillip F Pratt, et al.
Immunology|May 1, 1989
Renal allograft rejection: possible involvement of lymphokine-activated killer cellsJ A Kirby, J L Forsythe, G Proud, et al.
Expert Opinion on Therapeutic Targets|January 18, 2019
The MAP kinase-interacting kinases (MNKs) as targets in oncologyJianling Xie, James E Merrett, Kirk B Jensen, et al.
Pageof 47

Showing results (191-200 of 465) with videos related to

Sort By:
Pageof 47
FEBS Letters|August 15, 1977
Amino acid sequences at the two sites on glycogen synthetase phosphorylated by cyclic AMP-dependent protein kinase and their dephosphorylation by protein phosphatase-IIIC G Proud, D B Rylatt, S J Yeaman, et al.
Advances in Biological Regulation|May 24, 2014
Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple rolesJustin W Kenney, Claire E Moore, Xuemin Wang, et al.
The British Journal of Surgery|February 1, 1986
Aspirate cellularity as a rapid indicator of renal allograft rejectionR G Wilson, B K Shenton, R M Taylor, et al.
Scientific Reports|February 8, 2019
The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1Shervi Lie, Tingting Wang, Briony Forbes, et al.
Transfusion Medicine (Oxford, England)|December 1, 1991
Transfusion-induced immunosuppression and red cell clearanceP K Donnelly, G Proud, B K Shenton, et al.
The British Journal of Radiology|September 1, 1986
Computed tomography and sonography of cystic adventitial diseaseT P Fitzjohn, F E White, H W Loose, et al.
Transplantation|September 1, 1985
Control values of lymphocyte subsets in healthy volunteersT W Lennard, B K Shenton, G Proud, et al.
The Biochemical Journal|March 11, 2005
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Mark Rolfe, Laura E McLeod, Phillip F Pratt, et al.
Immunology|May 1, 1989
Renal allograft rejection: possible involvement of lymphokine-activated killer cellsJ A Kirby, J L Forsythe, G Proud, et al.
Expert Opinion on Therapeutic Targets|January 18, 2019
The MAP kinase-interacting kinases (MNKs) as targets in oncologyJianling Xie, James E Merrett, Kirk B Jensen, et al.
Pageof 47